Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study

Table 4 Statistical comparison of traditional cardiovascular risk markers and clinical characteristics based on ART drug regime in thestudy participants using one-way ANOVA

Parameter	AZT/3TC/NVP (n = 93)	TDF/3TC/EFV (n = 46)	TDF/3TC/ LPV/r (n = 11)	p-value	AZT/3TC/NVP Vs TDF/3TC/EFV p-value	AZT/3TC/NVP Vs TDF/3TC/LPV/r p-value	TDF/3TC/EFV Vs TDF/3TC/LPV/r p-value
BMI (Kg/m²)	25.71 ± 5.54	25.19 ± 5.18	24.04 ± 6.15	0.599	0.865	0.606	0.803
WC (cm)	90.30 ± 11.17	90.09 ± 11.49	88.82 ± 15.29	0.922	0.994	0.915	0.943
WHR	0.88 ± 0.04	0.87 ± 0.05	0.85 ± 0.06	0.041*	0.530	0.039*	0.216
SBP (mmHg)	123 ± 20	122 ± 25	112 ± 11	0.270	0.994	0.2.43	0.306
DBP (mmHg)	82 ± 8	81 ± 7	76 ± 5	0.073	0.823	0.059	0.152
ABI	0.91 ± 0.09	0.94 ± 0.06	0.92 ± 0.09	0.041*	0.039*	0.873	0.671
Nadir CD4+ T cells (cells/mm³)	295 ± 250	211 ± 177	216 ± 211	0.100	0.106	0.998	0.998
Current CD4+ T cells (cells/mm³)	549 ± 272	443 ± 245	393 ± 237	0.029*	0.041*	0.149	0.834
FPG (mmol/L)	4.40 ± 0.56	4.79 ± 1.13	4.32 ± 0.54	0.019*	0.020*	0.938	0.179
TC (mmol/L)	4.68 ± 1.04	4.46 ± 0.90	4.66 ± 0.60	0.432	0.404	0.997	0.810
TG (mmol/L)	2.20 ± 0.15	2.19 ± 0.14	2.23 ± 0.09	0.671	0.919	0.754	0.647
HDL-C (mmol/L)	1.20 ± 0.07	1.19 ± 0.06	1.18 ± 0.08	0.538	0.611	0.730	0.976
LDL-C (mmol/L)	2.49 ± 1.01	2.28 ± 0.09	2.46 ± 0.54	0.460	0.432	0.997	0.823

Data are presented as mean ± standard deviation. * = significant at P < 0.05. PAD Peripheral artery disease, ABI Ankle brachial index, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, WHR Waist to hip ratio, CVD Cardiovascular disease, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, FPG Fasting plasma glucose

ISSN: 1471-2458